Brian Carey’s legal practice focuses on advising a wide range of clients on federal legislative and regulatory issues impacting the life sciences and health care sectors. He primarily advises biotechnology, medical device companies, health care providers, medical trade associations and private equity investors. Brian serves as a co-chair of the firm's Administrative Law practice group.
His work with biopharma and medical technology companies includes advice on Medicare coverage and payment, and food and drug approval issues for innovative technologies. He regularly represents clients in matters before the Congress, Department of Health and Human Services, and federal agencies.More »